567 related articles for article (PubMed ID: 21103969)
1. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.
Neul C; Hofmann U; Schaeffeler E; Winter S; Klein K; Giacomini KM; Eichelbaum M; Schwab M; Nies AT
Br J Pharmacol; 2021 Mar; 178(6):1459-1474. PubMed ID: 33434947
[TBL] [Abstract][Full Text] [Related]
3. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
Motohashi H; Inui K
AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
[TBL] [Abstract][Full Text] [Related]
4. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
5. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Epigenetic Regulation of Organic Cation Transporters.
Kölz C; Schaeffeler E; Schwab M; Nies AT
Handb Exp Pharmacol; 2021; 266():81-100. PubMed ID: 33674913
[TBL] [Abstract][Full Text] [Related]
7. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics.
Staud F; Cerveny L; Ahmadimoghaddam D; Ceckova M
Int J Biochem Cell Biol; 2013 Sep; 45(9):2007-11. PubMed ID: 23831838
[TBL] [Abstract][Full Text] [Related]
8. Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics.
Damme K; Nies AT; Schaeffeler E; Schwab M
Drug Metab Rev; 2011 Nov; 43(4):499-523. PubMed ID: 21923552
[TBL] [Abstract][Full Text] [Related]
9. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).
Terada T; Inui K
Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and ontogeny of organic cation transporters in mice.
Alnouti Y; Petrick JS; Klaassen CD
Drug Metab Dispos; 2006 Mar; 34(3):477-82. PubMed ID: 16381671
[TBL] [Abstract][Full Text] [Related]
11. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D
Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
[TBL] [Abstract][Full Text] [Related]
13. Role of organic cation transporters in drug-drug interaction.
Koepsell H
Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523
[TBL] [Abstract][Full Text] [Related]
14. Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families.
Chen J; Brockmöller J; Seitz T; König J; Chen X; Tzvetkov MV
Biol Chem; 2017 Feb; 398(2):237-249. PubMed ID: 27676604
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
16. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations.
Omote H; Hiasa M; Matsumoto T; Otsuka M; Moriyama Y
Trends Pharmacol Sci; 2006 Nov; 27(11):587-93. PubMed ID: 16996621
[TBL] [Abstract][Full Text] [Related]
17. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice.
Schmitt A; Mössner R; Gossmann A; Fischer IG; Gorboulev V; Murphy DL; Koepsell H; Lesch KP
J Neurosci Res; 2003 Mar; 71(5):701-9. PubMed ID: 12584728
[TBL] [Abstract][Full Text] [Related]
18. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
Nakamura T; Yonezawa A; Hashimoto S; Katsura T; Inui K
Biochem Pharmacol; 2010 Dec; 80(11):1762-7. PubMed ID: 20813096
[TBL] [Abstract][Full Text] [Related]
19. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
[TBL] [Abstract][Full Text] [Related]
20. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Amphoux A; Vialou V; Drescher E; Brüss M; Mannoury La Cour C; Rochat C; Millan MJ; Giros B; Bönisch H; Gautron S
Neuropharmacology; 2006 Jun; 50(8):941-52. PubMed ID: 16581093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]